Market Cap

Collegium Pharmaceutical, Inc. Market Capitalization:

$1.44 Billion

USD as of Jan. 1, 2026

business Collegium Pharmaceutical, Inc. Company Profile

Collegium Pharmaceutical, Inc. Main Stock Listing

NASDAQ: COLL

Market Capitalization History of Collegium Pharmaceutical, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Collegium Pharmaceutical, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $1.44 B 36.94%
Jan. 1, 2025 $1.05 B -0.22%
Jan. 1, 2024 $1.05 B 8.75%
Jan. 1, 2023 $968.5 M 60.95%
Jan. 1, 2022 $601.8 M -26.06%
Jan. 1, 2021 $813.8 M 20.01%
Jan. 1, 2020 $678.1 M 25.64%
Jan. 1, 2019 $539.7 M -32.84%
Jan. 1, 2018 $803.7 M 41.74%
Jan. 1, 2017 $567.0 M -1.23%
Jan. 1, 2016 $574.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Collegium Pharmaceutical, Inc. Categories

United States languages Healthcare languages Drug Manufacturers—Specialty & Generic
United States Healthcare United States Drug Manufacturers—Specialty & Generic

Stocks & Indices

Collegium Pharmaceutical, Inc. has the following listings and related stock indices.


Stock: NASDAQ: COLL

Stock: FSX: 354

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.